Clinical Trial Update: Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab as palliative treatment for symptomatic malignant ascites in patients with advanced gastrointestinal cancers has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Malignant Ascites

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Malignant Ascites, Gastrointestinal Cancers | Phase 2 | Status: COMPLETED